Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model.

Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model. Abstract Text:

    akira mikiAkira Miki,yoshihiko yanoYoshihiko Yano,hirotaka katoHirotaka Kato,yasushi seoYasushi Seo,masamitsu kuriyamaMasamitsu Kuriyama,takeshi azumaTakeshi Azuma,yoshitake hayashiYoshitake Hayashi,akira mikiAkira Miki,yoshihiko yanoYoshihiko Yano,hirotaka katoHirotaka Kato,yasushi seoYasushi Seo,masamitsu kuriyamaMasamitsu Kuriyama,takeshi azumaTakeshi Azuma,yoshitake hayashiYoshitake Hayashi,

    Interferon (IFN) is a multifunctional cytokine which works as a suppressor of hepatocarcinogenesis. Pegylated interferon (PEG-IFN) is a modified form of IFN with different pharmacokinetics. We evaluated the anti-tumor effect of PEG-IFN using a rat hepatocarcinogenesis model. Male Fisher Rats were treated using the Solt and Faber model to induce liver cancer. IFN and PEG-IFN were administered from chemical initiation, and pre-neoplastic foci and neoplastic hepatocellular carcinoma (HCC) were examined at 4 and 40 weeks after chemical initiation, respectively. Apoptosis-related molecules such as p53 and Fas-L, proliferating cell nuclear antigen (PCNA), and oxidative stress-related molecules such as 8-hydroxydeoxyguanosine (8-OHdG) and thioredoxin (TRX) were assessed by immunohistochemical analysis and reverse transcriptase-polymerase chain reaction (RT-PCR). The expression of Notch-1, a molecule related to the regenerative and oncogenic processes was also examined. The generation of foci and HCC were significantly suppressed in IFN and PEG-IFN groups compared with the control group. Whereas PCNA and Notch-1 were strongly expressed in the foci and HCC, Fas-L was mainly detected in the surrounding hepatocytes. 8-OHdG and TRX were also detected in the foci. Although PCNA and Notch-1 were down-regulated in IFN- and PEG-IFN-treated groups, Fas-L was up-regulated in those groups. The activation of Notch-1 signaling and the accumulation of oxidative stress in the pre-neoplastic foci might be associated with the progression of HCC in the DEN-induced hepatocarcinogenesis model. The inhibitory effect of the PEG-IFN and IFN on hepatocarcinogenesis was almost the same, and this might be induced by the Fas-related apoptosis in the surrounding tissues.

    Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model. Publishing Authors By Initials

    a mikiA Miki,y yanoY Yano,h katoH Kato,y seoY Seo,m kuriyamaM Kuriyama,t azumaT Azuma,y hayashiY Hayashi,a mikiA Miki,y yanoY Yano,h katoH Kato,y seoY Seo,m kuriyamaM Kuriyama,t azumaT Azuma,y hayashiY Hayashi,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: International journal of oncology

    VOLUME: 32

    Page Numbers: 603-8

    Journal Abbreviation: Int. J. Oncol.

    ISSN: 1019-6439

    DAY: 22

    MONTH: Mar

    YEAR: 2008

    Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9306042

    Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model.

    AFFILIATION: Division of Molecular Medicine and Medical Genetics, International Center of Medical Research and Treatment (ICMRT), Kobe University Graduate School of Medicine, Kusunoki-cho, Kobe 650-0017, Japan.

    Country: Greece

    Greece Research PublicationGreece Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Int J Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News